S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10

PreveCeutical Medical Stock Forecast, Price & News

Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume694,224 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A

Receive PREV News and Ratings via Email

Sign-up to receive the latest news and ratings for PreveCeutical Medical and its competitors with MarketBeat's FREE daily newsletter.

About PreveCeutical Medical

PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products in the United States and Canada. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disorders; BSV Peptide Program; Non-Addictive Analgesic for pain management; and Dual Gene Therapy for type 2 diabetes and obesity. The company also develops a range of medicinal cannabis-based products. PreveCeutical Medical Inc. is headquartered in Vancouver, Canada.


See More Headlines

Industry, Sector and Symbol

Year Founded

Sales & Book Value

Annual Sales





Next Earnings Date
Not Optionable


Overall MarketRank

1.00 out of 5 stars

Analyst Opinion: 0.0Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

PreveCeutical Medical (CNSX:PREV) Frequently Asked Questions

What stocks does MarketBeat like better than PreveCeutical Medical?

Wall Street analysts have given PreveCeutical Medical a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but PreveCeutical Medical wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are PreveCeutical Medical's key executives?

PreveCeutical Medical's management team includes the following people:
  • Mr. Stephen Van Deventer, Chairman & CEO (Age 52, Pay $113.75k)
  • Dr. Makarand Jawadekar Ph.D., Chief Science Officer, Pres & Director (Age 70, Pay $79.53k)
  • Ms. Shabira Rajan CPA, CGA, CFO & Controller (Age 65, Pay $63.45k)
  • Dr. Harendra Parekh Ph.D., BSc., Hons I, MRPharmS, Chief Research Officer

What other stocks do shareholders of PreveCeutical Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other PreveCeutical Medical investors own include Aurora Cannabis (ACB), Equinix (EQIX), PreveCeutical Medical (PRVCF), Blue Energy (BLU), Biocept (BIOC), Baidu (BIDU), BlackBerry (BB), Alimentation Couche-Tard (ATD.B), (APHA) and Amarin (AMRN).

What is PreveCeutical Medical's stock symbol?

PreveCeutical Medical trades on the CNSX under the ticker symbol "PREV."

How do I buy shares of PreveCeutical Medical?

Shares of PREV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is PreveCeutical Medical's official website?

The official website for PreveCeutical Medical is www.preveceutical.com.

How can I contact PreveCeutical Medical?

The company can be reached via phone at 604-416-7777.

This page was last updated on 10/24/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.